Agaricus Muscarius, Allium Cepa, Arnica Montana, Hypericum Perforatum, Lycopodium Clavatum, Mercurius Solubilis, Phosphorus, Plumbum Metallicum
Generic Name: agaricus muscarius, allium cepa, arnica montana, hypericum perforatum, lycopodium clavatum, mercurius solubilis, phosphorus, plumbum metallicum
Brand Names:
Neuralgia Hp
INDICATIONS: For temporary relief of symptoms of numbness, tingling, muscle cramps, and nerve pain.
Overview
INDICATIONS: For temporary relief of symptoms of numbness, tingling, muscle cramps, and nerve pain.
Uses
INDICATIONS: For temporary relief of symptoms of numbness, tingling, muscle cramps, and nerve pain.
Dosage
DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place
Frequently Asked Questions
What is Agaricus Muscarius, Allium Cepa, Arnica Montana, Hypericum Perforatum, Lycopodium Clavatum, Mercurius Solubilis, Phosphorus, Plumbum Metallicum used for?▼
INDICATIONS: For temporary relief of symptoms of numbness, tingling, muscle cramps, and nerve pain.
What are the important warnings for Agaricus Muscarius, Allium Cepa, Arnica Montana, Hypericum Perforatum, Lycopodium Clavatum, Mercurius Solubilis, Phosphorus, Plumbum Metallicum?▼
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place
Related Medications
Triflupromazine Hydrochloride
triflupromazine hydrochloride
Manufactured by BRISTOL MYERS SQUIBB. Dosage form: TABLET. Route: ORAL. Active ingredients: TRIFLUPROMAZINE HYDROCHLORIDE (25MG). Application: NDA011123.
Benralizumab
benralizumab
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Benralizumab is a humanized monoclonal antibody (IgG1/κ-class) selective for interleukin-5 receptor alpha subunit (IL-5Rα). Benralizumab is produced in Chinese hamster ovary cells by recombinant DNA technology. Benralizumab has a molecular weight of approximately 150 kDa. FASENRA (benralizumab) injection is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution for subcutaneous injection.
Siltuximab
siltuximab
Interleukin-6 Antagonist [EPC]
11 DESCRIPTION Siltuximab is a human-mouse chimeric monoclonal antibody that binds human interleukin-6 (IL-6) and is produced by Chinese hamster ovary cells. SYLVANT (siltuximab) for injection is supplied as a sterile, white, preservative free, lyophilized powder in single-dose vials. Each SYLVANT 100 mg single-dose vial contains 100 mg siltuximab, 3.7 mg L-histidine (from L-histidine and L-histidine monohydrochloride monohydrate), 0.8 mg polysorbate 80, and 169 mg sucrose.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.